February 21, 2018
Chang VW, Langa KM, Weir D, Iwashyna TJ. The obesity paradox and incident cardiovascular disease: A population-based study. PLoS One 2017; 12: e0188636. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0188636
March 21, 2018
de Glas NA, Kiderlen M, Vandenbroucke JP, de Craen AJ, Portielje JE, van de Velde CJ, Liefers GJ, Bastiaannet E, Le Cessie S. Performing survival analyses in the presence of competing risks: a clinical example in older breast cancer patients. Journal of the National Cancer Institute. 2016 May 1;108(5):djv366. https://doi.org/10.1093/jnci/djv366
April 11, 2018
Fewell Z, Davey Smith G, Sterne JAC. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007 Sep 15;166(6):646-55. https://academic.oup.com/aje/article/166/6/646/89040
June 20, 2018
Samama CM, Rosencher N, Kleine E, Feuring M, Brueckmann M, Clemens A, Gullberg J, Frostick SP. Observational study of dabigatran etexilate 150 mg in patients with moderate renal impairment undergoing elective total hip or knee replacement. Thrombosis Research. 2016 Jul 1;143:103-10. https://pubmed.ncbi.nlm.nih.gov/27208980/
July 18, 2018
Hernán MA, Robins JM. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. Am J Epidemiol. 2016 Apr 15;183(8):758–64. https://www.ncbi.nlm.nih.gov/pubmed/26994063
September 19, 2018
Rothman KJ, Greenland S. Planning Study Size Based on Precision Rather Than Power. Epidemiology. 2018 Sep;29(5):559–603. https://pubmed.ncbi.nlm.nih.gov/29912015/
November 21, 2018
Rombach I, Gray AM, Jenkinson C, Murray DW, Rivero-Arias O. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. BMC Medical Research Methodology. 2018 Aug;18:107. https://doi.org/10.1186/s12874-018-0542-6
Berlin Epidemiological Methods Colloquium (BEMC) 